Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its anal...
FY 2025
Apr 15, 2026
Q3 2025
Nov 18, 2025
Q2 2025
Aug 15, 2025
Q1 2025
May 15, 2025
FY 2024
Mar 31, 2025